MAPT and Alzheimer disease: In conclusion, this study revealed reduced regional levels of SV2A in brain tissues and BDEVs in AD patients than in NCs, particularly in those carrying the APOE ε4 allele, as well as correlations of SV2A with Aβ and tau pathologies.